CMS Announces Two Quality and Safety Initiatives Related to Antipsychotic Medication
Posted on January 19, 2023 by Kari Everson
On Jan. 18, the Center for Medicare and Medicaid Services (CMS) announced two initiatives in quality and safety oversight memo 23-05-NH in response to the Biden-Harris administration effort to improve nursing home transparency, safety, and quality. CMS intends to conduct offsite nursing home audits to determine if the nursing home correctly coded diagnoses for residents using antipsychotic medication. CMS will change how citations under dispute are posted.
CMS Announces Two Quality and Safety Initiatives Related to Antipsychotic Medication
Members Only
The resource you are trying to access is a Members Only Resource. If you are a member of LeadingAge Minnesota, simply log in. If you forgot your password, click on the link and we will e-mail it to you.
Want to become a member? Click here for further information.
Comments
Add a comment
Members must sign in to comment
You must be a member to comment on this article. If you are already a member, please log in. Not a member? Learn how to join »
No one has commented on this article yet. Please post a comment below.